BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28

• Press Releases

  ITM Receives U.S. FDA Fast Track Designation for ITM-94 as a Diagnostic Agent for Clear Cell Renal Cell Carcinoma

  November 17, 2025

   · 

  4 min read
• Press Releases

  Polpharma Biologics Confirms U.S. Launch of Tyruko® (natalizumab), the First and Only Biosimilar for Multiple Sclerosis

  November 17, 2025

   · 

  2 min read
• Press Releases

  Agomab Announces Positive Topline Phase 2a Data for Ontunisertib in Fibrostenosing Crohn’s Disease

  November 17, 2025

   · 

  6 min read
• Press Releases

  EMA Positive Opinion for Orphan Drug Designation to BioInvent’s BI‑1808 for the Treatment of Cutaneous T-cell Lymphoma

  November 17, 2025

   · 

  5 min read
• Press Releases

  Accession Therapeutics doses first patient in Phase 1 clinical trial of TROCEPT-01 (ATTR-01), a novel cancer immunotherapy

  November 17, 2025

   · 

  4 min read
• Press Releases

  Cardiovalve Submits CE File for Approval Following Successful TARGET Study Completion

  November 17, 2025

   · 

  3 min read
• Press Releases

  Nxera Announces Focused Restructuring to Enhance Path to Profitability

  November 17, 2025

   · 

  8 min read
• Press Releases

  Vicore to Present at The 2025 Jefferies Global Healthcare Conference in London

  November 17, 2025

   · 

  1 min read
• Press Releases

  James M. O’Brien Appointed Chief Financial Officer at Mesoblast

  November 17, 2025

   · 

  6 min read
• Press Releases

  Adcytherix Powers Ahead: Technology and Team in Place to Deliver Strategy and Build an ADC Powerhouse

  November 17, 2025

   · 

  5 min read